中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents

Value of common clinical indices and noninvasive liver fibrosis scores in the diagnosis of advanced liver fibrosis in hepatic-type Wilson's disease in China

DOI: 10.3969/j.issn.1001-5256.2021.03.014
  • Received Date: 2020-09-07
  • Accepted Date: 2020-10-09
  • Published Date: 2021-03-20
  •   Objective  To investigate the association of common clinical indices and noninvasive liver fibrosis scores with hepatic-type Wilson's disease (WD) in Chinese patients and their ability to identify advanced liver fibrosis.  Methods  A retrospective analysis was performed for the clinical data of 236 Chinese patients with WD who were diagnosed and treated in Beijing YouAn Hospital and China-Japan Friendship Hospital from May 1996 to April 2020. A total of 26 patients with hepatic-type WD who underwent liver pathological examination and had complete clinical data were enrolled; the METAVIR score was used to determine liver fibrosis stage, and the patients were divided into advanced liver fibrosis (F3 and F4 stages) group and non-advanced liver fibrosis (F0, F1, and F2 stages) groups. Three noninvasive liver fibrosis scores [Sheth index, aspartate aminotransferase-to-platelet ratio index (APRI), and fibrosis-4 (FIB-4) index] were calculated for both groups, and the above indices and related clinical indices were compared between the two groups. The independent samples t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the Fisher's exact test was used for comparison of categorical data between two groups. The Spearman rank correlation test was used for further analysis of indices with statistical significance, and the clinical indices and scoring criteria correlated with liver fibrosis degree were screened out; the receiver operating characteristic (ROC) curve was plotted, and the area under the ROC curve (AUC) was calculated.  Results  Most of the patients in this study developed the disease in childhood and adolescence, and among these patients, 10 (38.5%) had positive K-F ring and 17 (65%) were in the stage of advanced liver fibrosis. There were significant differences between the advanced liver fibrosis group and the non-advanced liver fibrosis group in white blood cell count (WBC) (Z=-2.102, P=0.036), hemoglobin (Hb) (t=-2.860, P=0.009), platelet count (PLT) (t=-4.053, P < 0.001), direct bilirubin (DBil) (Z=-2.130, P=0.033), albumin (Alb) (t=-2.875, P=0.008), and Sheth index (Z=-3.369, P=0.001). WBC, Hb, PLT, and Alb were negatively correlated with liver fibrosis degree in WD patients (r=-0.587, -0.610, -0.656, and -0.411, all P < 0.05), and DBil and Sheth index were positively correlated with liver fibrosis degree (r=0.486 and 0.711, both P < 0.05). The ROC curve analysis showed that WBC, DBil, Sheth index, Hb, PLT, and Alb had an AUC of > 0.7, among which Sheth index had the largest AUC of 0.908, with a sensitivity of 70.6%, a specificity of 100.0%, a positive predictive value of 100.0%, and a negative predictive value of 64.3%.  Conclusion  Sheth index has a better diagnostic efficiency than the other clinical indices alone and can well identify advanced liver fibrosis in Chinese patients with hepatic-type WD.

     

  • loading
  • [1]
    CZŁONKOWSKA A, LITWIN T, DUSEK P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4(1): 21. DOI: 10.1038/s41572-018-0018-3
    [2]
    GITLIN JD. Wilson disease[J]. Gastroenterology, 2003, 125(6): 1868-1877. DOI: 10.1053/j.gastro.2003.05.010
    [3]
    ZHONG HJ, SUN HH, XUE LF, et al. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis[J]. World J Gastroenterol, 2019, 25(3): 378-387. DOI: 10.3748/wjg.v25.i3.378
    [4]
    MERLE U, SCHAEFER M, FERENCI P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: A cohort study[J]. Gut, 2007, 56(1): 115-120. DOI: 10.1136/gut.2005.087262
    [5]
    BRUHA R, MARECEK Z, POSPISILOVA L, et al. Long-term follow-up of Wilson disease: Natural history, treatment, mutations analysis and phenotypic correlation[J]. Liver Int, 2011, 31(1): 83-91. DOI: 10.1111/j.1478-3231.2010.02354.x
    [6]
    ROCKEY DC, CALDWELL SH, GOODMAN ZD, et al. Liver biopsy[J]. Hepatology, 2009, 49(3): 1017-1044. DOI: 10.1002/hep.22742
    [7]
    SIDDIQUI MS, YAMADA G, VUPPALANCHI R, et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage[J]. Clin Gastroenterol Hepatol, 2019, 17(9): 1877-1885. DOI: 10.1016/j.cgh.2018.12.031
    [8]
    MARELLA HK, REDDY YK, JIANG Y, et al. Accuracy of noninvasive fibrosis scoring systems in African American and white patients with nonalcoholic fatty liver disease[J]. Clin Transl Gastroenterol, 2020, 11(4): e00165. DOI: 10.14309/ctg.0000000000000165
    [9]
    SCHMOYER CJ, KUMAR D, GUPTA G, et al. Diagnostic accuracy of noninvasive tests to detect advanced hepatic fibrosis in patients with hepatitis C and end-stage renal disease[J]. Clin Gastroenterol Hepatol, 2020, 18(10): 2332-2339. DOI: 10.1016/j.cgh.2020.02.019
    [10]
    PATERNOSTRO R, PFEIFFENBERGER J, FERENCI P, et al. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease[J]. Liver Int, 2020, 40(4): 894-904. DOI: 10.1111/liv.14368
    [11]
    SINI M, SORBELLO O, CIVOLANI A, et al. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease[J]. Dig Liver Dis, 2012, 44(6): 487-491. DOI: 10.1016/j.dld.2011.12.010
    [12]
    European Association for Study of Liver. EASL clinical practice guidelines: Wilson's disease[J]. J Hepatol, 2012, 56(3): 671-685. DOI: 10.1016/j.jhep.2011.11.007
    [13]
    BEDOSSA P, POYNARD T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group[J]. Hepatology, 1996, 24(2): 289-293. DOI: 10.1002/hep.510240201
    [14]
    FERENCI P, STREMMEL W, CZŁONKOWSKA A, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease[J]. Hepatology, 2019, 69(4): 1464-1476. DOI: 10.1002/hep.30280
    [15]
    SOKOL RJ, TWEDT D, MCKIM JM Jr, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis[J]. Gastroenterology, 1994, 107(6): 1788-1798. DOI: 10.1016/0016-5085(94)90822-2
    [16]
    CROSAS-MOLIST E, FABREGAT I. Role of NADPH oxidases in the redox biology of liver fibrosis[J]. Redox Biol, 2015, 6: 106-111. DOI: 10.1016/j.redox.2015.07.005
    [17]
    ZISCHKA H, LICHTMANNEGGER J. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models[J]. Ann N Y Acad Sci, 2014, 1315: 6-15. DOI: 10.1111/nyas.12347
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Article Metrics

    Article views (496) PDF downloads(57) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return